News
FDA chooses flu vaccine strains despite cancelled meeting
The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.
News
Pharma furious as UK Statutory Scheme rebate rate soars
The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.
News
Rumour confirmed as Mallinckrodt merges with Endo
Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.
Sales & Marketing
Regulators vs weight loss ads: Time to rethink the rules?
“Medicated weight loss isn’t cheating.” Since I first wrote about the rise of
News
Kelun-Biotech first to bag TROP2 approval in lung cancer
Kelun-Biotech wins first global regulatory approval - in China - for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
